View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Avolta Capital Markets Day 2025 - Save The Date

Avolta AG / Key word(s): Miscellaneous Avolta Capital Markets Day 2025 - Save The Date 29.01.2025 / 06:30 CET/CEST Please save the date for Avolta’s 2025 Capital Markets Day. The event is set to be held in Barcelona on Thursday 26 June and will be hosted by Avolta CEO Xavier Rossinyol and CFO Yves Gerster.  More details to follow on our . For further information: CONTACT   Rebecca McClellan Cathy Jongens     Global Head Investor Relations Director Corporate  Communications Phone : 5  Phone : 28      End of Media Rel...

Moody's Ratings assigns provisional ratings to Espoir-2502 backed by a...

2025 年1月29日、 東京、 ムーディーズSFジャパン株式会社( 以下「ムーディーズ」) は、 下記案件 の予備格付付与を公表した。 本邦法令上の格付付与日は2025年1月28日である。. 案件名: Espoir-2502 クラス、 予定配当率/ 利率、 格付 優先受益権、 固定、 Aaa 信託ABL、 固定、 Aaa. 発行総額: 401 億円 発行日: 2025 年2月27日 最終償還期日: 2035 年4月25日 裏付債権:...

Moody's Ratings assigns provisional ratings to Espoir-2502 backed by a...

Moody's Ratings (Moody's) has assigned provisional ratings to the following transaction. The complete rating action is as follows: Transaction Name: Espoir-2502 Class, Scheduled Dividend/Interest Rate, Rating Senior Beneficial Interests, Fixed, (P)Aaa (sf) Trust ABL, Fixed, (P)Aaa (sf) Total...

Felix Fischer ... (+6)
  • Felix Fischer
  • Haidje Rustau
  • Ian Wong
  • Jayanth Kandalam
  • Peter Low
  • Si Yong Ng

Lucror Analytics - Morning Views Europe

In today's Morning Views publication we comment on developments of the following high yield issuers: Scan Global Logistics, Nokia, Banijay, Forgital, Engineering Group, Synthomer, Intrum, Ineos, Merlin Entertainments, Mahle, Aggreko

Charter Hall Group: Update to credit opinion

Our credit view of this issuer reflects its strong credit metrics, offset by its potential long-term risk of forced asset sales in a weak market, triggered by liquidity reviews.

Will County CUSD 209-U, IL: Update to credit analysis

Our credit view of Will County CUSD 209-U reflects its robust financial position, solid local economy with enrollment expected to stabilize, and moderate leverage.

 PRESS RELEASE

89bio, Inc. Announces Pricing of $250.0 Million Public Offering of Com...

89bio, Inc. Announces Pricing of $250.0 Million Public Offering of Common Stock and Pre-Funded Warrants SAN FRANCISCO, Jan. 28, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (“89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced the pricing of its previously announced upsized underwritten public offering of 21,671,428 shares of its common stock at a public offering price per share of $8.75 and, in lieu of common stock to a certain investor,...

General Principles for Assessing Environmental, Social and Governance ...

This methodology describes our approach to rating general principles for assessing environmental, social and governance risks.

General Principles for Assessing Environmental, Social and Governance ...

This methodology describes our approach to rating general principles for assessing environmental, social and governance risks.

 PRESS RELEASE

Webuy Global Ltd. Receives Nasdaq Notification Regarding Non-Complianc...

Webuy Global Ltd. Receives Nasdaq Notification Regarding Non-Compliance with Minimum Bid Price Rule Singapore, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Webuy Global Ltd. (Nasdaq: WBUY) (the “Company”), today announced that it received a letter on January 22, 2025, from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company has not regained compliance with Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”), which requires listed securities to maintain a minimum bid price of $1.00 per share. As a result, the Nasdaq staff has issued a ...

 PRESS RELEASE

Akero Therapeutics Announces Pricing of Upsized Public Offering of Com...

Akero Therapeutics Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants SOUTH SAN FRANCISCO, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic disease marked by high unmet medical need, announced today the pricing of an upsized underwritten public offering of 5,333,420 shares of its common stock at a public offering price of $48.00 per share and, in lieu of common stock to certain investors that so choose, pre-funded warrants ...

 PRESS RELEASE

First Savings Financial Group, Inc. Reports Financial Results for the ...

First Savings Financial Group, Inc. Reports Financial Results for the First Fiscal Quarter Ended December 31, 2024 JEFFERSONVILLE, Ind., Jan. 28, 2025 (GLOBE NEWSWIRE) -- First Savings Financial Group, Inc. (NASDAQ: FSFG - news) (the "Company"), the holding company for First Savings Bank (the "Bank"), today reported net income of $6.2 million, or $0.89 per diluted share, for the quarter ended December 31, 2024, compared to net income of $920,000, or $0.13 per diluted share, for the quarter ended December 31, 2023. Excluding nonrecurring items, the Company reported net income of $4.3 milli...

Benjaphol Suthwanish
  • Benjaphol Suthwanish

SCGP (SCGP TB) - 4Q24: Reported Net Loss, Causing Net Profit In 2024 D...

SCGP reported a net loss of Bt58m in 4Q24, resulting from a foreign exchange and extra loss. Excluding such items, core profit in 4Q24 was in line with our expectation and 28% below consensus estimate. Core profit in 4Q24 decreased both qoq and yoy from lower sales and ASP in all businesses, including the recognition of higher losses from Fajar. However, we still expect to see 1Q25 results turn to net profit, but there is still a risk of pressure on ASP. Maintain HOLD. Target price: Bt18.00.

Benjaphol Suthwanish
  • Benjaphol Suthwanish

Thailand Daily - Wednesday, January 29, 2025

KEY HIGHLIGHTS Update SCGP (SCGP TB/HOLD/Bt16.3/Target: Bt18.00) 4Q24: Reported net loss, causing net profit in 2024 down 30%yoy.

Clorox Company (The): Update to Discussion of Key Credit Factors

Our credit view of this issuer reflects its modest financial leverage target, against its limited geographic diversity outside the US.

APOLLO Series 2025-1 Trust: Pre-Sale - Norfina's first RMBS transactio...

Our credit view of APOLLO Series 2025-1 Trust transaction, reflecting our analysis of the assets and securitisation structure.

 PRESS RELEASE

McEwen Mining: 2024 Production Within Guidance; 2025 Guidance: Stable ...

McEwen Mining: 2024 Production Within Guidance; 2025 Guidance: Stable Production and Cost/Oz TORONTO, Jan. 28, 2025 (GLOBE NEWSWIRE) -- McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) is pleased to report full-year 2024 consolidated production of 135,900 gold equivalent ounces (“GEOs”)(1), within our guidance range for the year (press release dated ). During 2024, Gold Bar and San Jose produced 44,600 and 60,100 GEOs, respectively, slightly exceeding the top end of our guidance ranges for those operations. At the Fox Complex, we produced 30,150 GEOs, which was below annual guidance due to a st...

Structured Finance: December 2024 structured rating transitions

Monthly update on structured finance credit trends with a focus on current month and trailing 12-month upgrade and downgrade rates

Moody's Ratings assigns ratings to two classes of notes issued by Park...

Moody's Ratings (Moody's) has assigned ratings to two classes of notes issued by Park Blue CLO 2024-VI, Ltd. (the Issuer or Park Blue CLO 2024-VI):   U.S.$263,500,000 Class A-1 Senior Secured Floating Rate Notes due 2038, Assigned Aaa (sf) U.S.$12,750,000 Class E Deferrable Mezzanine Floating Rat...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch